However a clinical application of CpdA-like molecules for the treatment of inflammatory and Th1-mediated autoimmune diseases must be carefully studied taking into account the association of GATA-3 and IL-5 with allergic diseases such as asthma pathogenesis. This evidence concerns the gene GATA3 and asthma.